Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings (DE:2PQ)
:2PQ
RESEARCH TOOLSreports
Total Valuation
Organogenesis Holdings has a market cap or net worth of $508.19M. The enterprise value is $452.50M.
Market Cap$508.19M
Enterprise Value$452.50M
Share Statistics
Organogenesis Holdings has 126,828,094 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding126,828,094
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Organogenesis Holdings’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.09%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.09%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee554.71K
Profits Per Employee990.79
Employee Count869
Asset Turnover0.97
Inventory Turnover4.41
Valuation Ratios
The current PE Ratio of Organogenesis Holdings is 489.38. Organogenesis Holdings’s PEG ratio is -2.12.
PE Ratio489.38
PS Ratio1.28
PB Ratio1.60
Price to Fair Value1.60
Price to FCF100.90
Price to Operating Cash Flow29.66
PEG Ratio-2.12
Income Statement
In the last 12 months, Organogenesis Holdings had revenue of 482.04M and earned 861.00K in profits. Earnings per share was -0.05.
Revenue482.04M
Gross Profit366.30M
Operating Income-1.28M
Pretax Income-2.81M
Net Income861.00K
EBITDA-1.28M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was 14.21M and capital expenditures -10.03M, giving a free cash flow of 4.18M billion.
Operating Cash Flow14.21M
Free Cash Flow4.18M
Free Cash Flow per Share0.03
Dividends & Yields
Organogenesis Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.78
52-Week Price Change78.76%
50-Day Moving Average4.01
200-Day Moving Average3.18
Relative Strength Index (RSI)47.40
Average Volume (3m)0.00
Important Dates
Organogenesis Holdings upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Organogenesis Holdings as a current ratio of 3.69, with Debt / Equity ratio of 16.47%
Current Ratio3.69
Quick Ratio3.35
Debt to Market Cap0.10
Net Debt to EBITDA71.91
Interest Coverage Ratio-0.83
Taxes
In the past 12 months, Organogenesis Holdings has paid -3.67M in taxes.
Income Tax-3.67M
Effective Tax Rate1.31
Enterprise Valuation
Organogenesis Holdings EV to EBITDA ratio is -256.50, with an EV/FCF ratio of 78.81.
EV to Sales0.68
EV to EBITDA-256.50
EV to Free Cash Flow78.81
EV to Operating Cash Flow23.16
Balance Sheet
Organogenesis Holdings has $135.57M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$92.26M billion.
Cash & Marketable Securities$135.57M
Total Debt$0.00
Net Cash-$92.26M
Net Cash Per Share-$0.73
Tangible Book Value Per Share$2.61
Margins
Gross margin is 74.32%, with operating margin of -0.27%, and net profit margin of 0.18%.
Gross Margin74.32%
Operating Margin-0.27%
Pretax Margin-0.58%
Net Profit Margin0.18%
EBITDA Margin-0.27%
EBIT Margin-0.26%
Analyst Forecast
The average price target for Organogenesis Holdings is $5.26, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.26
Price Target Upside32.83% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―